0001792522-26-000001.txt : 20260305 0001792522-26-000001.hdr.sgml : 20260305 20260305132255 ACCESSION NUMBER: 0001792522-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260305 DATE AS OF CHANGE: 20260305 EFFECTIVENESS DATE: 20260305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MindImmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001792522 ORGANIZATION NAME: EIN: 812613707 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-565904 FILM NUMBER: 26725302 BUSINESS ADDRESS: STREET 1: 130 FLAGG ROAD CITY: KINGSTON STATE: RI ZIP: 02881 BUSINESS PHONE: 401-225-4612 MAIL ADDRESS: STREET 1: 130 FLAGG ROAD CITY: KINGSTON STATE: RI ZIP: 02881 D/A 1 primary_doc.xml X0708 D/A LIVE 0001792522 MindImmune Therapeutics, Inc. 130 FLAGG ROAD KINGSTON RI RHODE ISLAND 02881 401-225-4612 DELAWARE None None Corporation true Isaac Stoner 130 Flagg Road Kingston RI RHODE ISLAND 02881 Executive Officer Director CEO Bradley Margus 130 Flagg Road Kingston RI RHODE ISLAND 02881 Director Christopher O'Donnell 130 Flagg Road Kingston RI RHODE ISLAND 02881 Director Reetika Bhardwaj 130 Flagg Road Kingston RI RHODE ISLAND 02881 Director Pharmaceuticals Decline to Disclose 06b true 0001792522-25-000002 2025-11-24 false true true false 0 17014485 15218343 1796142 The Issuer also converted previously issued promissory notes valued at $7,731,294 into shares of its Series A-3(A) Preferred Stock. false 15 0 0 0 true false MindImmune Therapeutics, Inc. /s/ Isaac Stoner Isaac Stoner CEO 2026-03-05